Publication | Closed Access

Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, Pemetrexed disodium, ALIMTA™ and cisplatin: A multicenter phase II trial

Pemetrexed DisodiumMedicineMetronomic TherapyPharmacologyBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyFront-line TreatmentLung CancerMolecular OncologyRadiologyHealth Sciences